Description: Avricore Health Inc. manufactures and sells over-the-counter (OTC) products in Canada. The company's OTC products portfolio includes Hema-Fer, a natural iron supplement for use in pregnancy; CortiVera-H & SennAce creams and ointments to pharmacies; Ferrous Fumarate tablets and capsules; and Cortivera and Cortivera Plus creams and ointments for a range of minor skin irritations, allergic reactions, and eczema. It also distributes INSTI HIV 1/HIV 2 rapid antibody tests; and PhytoCann Complex, a blend of non-cannabis phytocannabinoids, along with other ingredients that support the endocannabinoid system. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is headquartered in Richmond, Canada.
Home Page: www.avricorehealth.com
789 West Pender Street
Vancouver,
BC
V6C 1H2
Canada
Phone:
604 773 8943
Officers
| Name | Title |
|---|---|
| Mr. Hector Bremner | CEO & Director |
| Ms. Kiriaki Smith CPA, CFO, CGA, CPA | CFO & Corp. Sec. |
| Mr. Rodger Seccombe | Head of Healthtab Division & Director |
| Mr. Will Seccombe | Communications Advisor |
| Dr. Allan Shapiro | Mang. of Bus. Devel. |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 14.5139 |
| Price-to-Sales TTM: | 28.3747 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |